An inpatient educational program for chronic kidney disease.
Chronic kidney disease
Education program
Predialysis
Renal function
Journal
Clinical and experimental nephrology
ISSN: 1437-7799
Titre abrégé: Clin Exp Nephrol
Pays: Japan
ID NLM: 9709923
Informations de publication
Date de publication:
Apr 2019
Apr 2019
Historique:
received:
24
06
2018
accepted:
08
10
2018
pubmed:
21
10
2018
medline:
30
7
2019
entrez:
21
10
2018
Statut:
ppublish
Résumé
Chronic kidney disease (CKD) is a significant health problem in Japan, and prevention programs to slow disease progression are necessary. In this study, we evaluated the effectiveness of a 1-week inpatient education program, delivered during the predialysis stage of CKD, in slowing the deterioration in renal function over the subsequent 2 years, and identified factors influencing the program's effectiveness. We retrospectively evaluated the estimated glomerular filtration rate (eGFR) of 105 consecutive patients who completed the program, at the following time points: 6 months prior to program initiation, at program initiation and, at 6, 12, 18, and 24 months after the program. To identify factors predictive of program effectiveness, we classified patients into a Responder and Non-responder group. In comparison with the rate of deterioration in renal function (mL/min/1.73 m Although the effectiveness of our program declined over time, it did produce an overall slowing in the rate of renal function deterioration over the 2-year period of observation after discharge. This slowing of CKD progression was more pronounced in patients with low UP levels, indicating that education programs should be considered while these levels are still low. Furthermore, the program still offers benefits to patients with CKD stages 4-5.
Sections du résumé
BACKGROUND
BACKGROUND
Chronic kidney disease (CKD) is a significant health problem in Japan, and prevention programs to slow disease progression are necessary. In this study, we evaluated the effectiveness of a 1-week inpatient education program, delivered during the predialysis stage of CKD, in slowing the deterioration in renal function over the subsequent 2 years, and identified factors influencing the program's effectiveness.
METHODS
METHODS
We retrospectively evaluated the estimated glomerular filtration rate (eGFR) of 105 consecutive patients who completed the program, at the following time points: 6 months prior to program initiation, at program initiation and, at 6, 12, 18, and 24 months after the program. To identify factors predictive of program effectiveness, we classified patients into a Responder and Non-responder group.
RESULTS
RESULTS
In comparison with the rate of deterioration in renal function (mL/min/1.73 m
CONCLUSIONS
CONCLUSIONS
Although the effectiveness of our program declined over time, it did produce an overall slowing in the rate of renal function deterioration over the 2-year period of observation after discharge. This slowing of CKD progression was more pronounced in patients with low UP levels, indicating that education programs should be considered while these levels are still low. Furthermore, the program still offers benefits to patients with CKD stages 4-5.
Identifiants
pubmed: 30341571
doi: 10.1007/s10157-018-1660-5
pii: 10.1007/s10157-018-1660-5
doi:
Types de publication
Journal Article
Langues
eng
Pagination
493-500Références
Hypertens Res. 2011 Oct;34(10):1106-10
pubmed: 21796127
PLoS One. 2016 Mar 21;11(3):e0151422
pubmed: 26999730
Diabetes Res Clin Pract. 2012 Nov;98(2):249-56
pubmed: 23036785
Ann Intern Med. 1995 Nov 15;123(10):754-62
pubmed: 7574193
Nihon Jinzo Gakkai Shi. 2014;56(5):553-99
pubmed: 25130031
Kidney Int. 2001 Sep;60(3):1131-40
pubmed: 11532109
Am J Kidney Dis. 2009 Jun;53(6):982-92
pubmed: 19339088
Int Urol Nephrol. 2018 Feb;50(2):301-312
pubmed: 28856498
Kidney Int. 1985 Jan;27(1):58-65
pubmed: 3981873
Lancet. 2010 Jun 12;375(9731):2073-81
pubmed: 20483451
Nihon Jinzo Gakkai Shi. 2013;55(5):956-65
pubmed: 23980481
Am J Kidney Dis. 2016 Sep;68(3):353-70
pubmed: 27020884
Diabetes Care. 2013 Oct;36(10):2960-7
pubmed: 23835695
Ther Apher Dial. 2013 Dec;17(6):567-611
pubmed: 24330555
Diabetes Res Clin Pract. 1999 Nov;46(2):135-41
pubmed: 10724092
Eur J Intern Med. 2015 Oct;26(8):640-5
pubmed: 26186813
Clin Exp Nephrol. 2009 Dec;13(6):621-30
pubmed: 19513802
Am J Med. 2015 Jan;128(1):68-76
pubmed: 25149427
PLoS One. 2018 Jan 17;13(1):e0190493
pubmed: 29342207
Am J Kidney Dis. 2011 Aug;58(2):235-42
pubmed: 21664016